MHYB.NE

Mackenzie Global High Yield Fixed Income ETF

Cboe CACADEQUITY DELAYED

17.57

▲ 0.04 (0.23%)

MARKET · —

Price

1D — H — L — Range — Vol —

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw

Open

—

Prev close

17.53

Day high

17.57

Day low

17.57

Volume

Market cap

—

P/E (TTM)

—

52W range

17.28 – 18.35

Trailing performance

Price return · vs SPY

Returnvs SPY

-0.28% +1.1%

-0.28% -4.0%

-0.68% -3.8%

-2.07% -13.1%

YTD

-2.12% -14.4%

-2.93% -22.9%

+3.85% -70.3%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on MHYB.NE open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Create free account Sign in

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

17.56

+0.06% from price

SMA 20

17.55

-0.13% from price

SMA 50

17.59

-0.36% from price

SMA 100

17.63

-0.35% from price

SMA 200

17.75

-1.22% from price

EMA 12

17.56

+0.07% from price

EMA 26

17.57

+0.02% from price

EMA 50

17.59

-0.11% from price

RSI (14)

39.4

Neutral

MACD (12,26,9)

-0.01

Hist 0.00

ATR (14)

0.04

0.24% of price

Realised vol 30D

2.1%

Annualised

Bollinger upper

17.60

20, 2σ

Bollinger lower

17.51

20, 2σ

50 / 200 cross

Death

17.59 vs 17.75

Trend bias

Below 200

-1.22%

Options chain

Account required

ExpirySpot 17.57

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.07

Less volatile than market

Correlation to SPY

0.29

Largely independent

Realised vol 30D

2.1%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-3.7%

Peak to trough

Max drawdown 5Y

-18.8%

Peak to trough

ATR 14

0.04

0.24% of price

Beta (reported)

—

5Y monthly, from filing

Headlines

MHYB.NE · links out to the publisher

Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion PR Newswire · 9m ago India police used excessive force during protests: Amnesty AFP · 12m ago AstraZeneca’s Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue? Insider Monkey · 14m ago California expected to seek TV channel sales from Paramount-Warner, WSJ reports Reuters · 17m ago Here's the Smartest S&P 500 Dividend Stock to Buy With $1,000 Right Now -- and It's Sporting a 6.8% Dividend Yield Motley Fool · 19m ago Walmart's top-rated mini dresser is just $26 during a Flash deal TheStreet · 24m ago Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery? Insider Monkey · 25m ago The “No-Contest Clause”: One Sentence That Makes Challenging Your Will Cost a Child Everything You Left Them. 24/7 Wall St. · 25m ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.